We have just completed our Seed funding round, securing an impressive 2 million USD from Tangent Line Ventures and Peleton.

News

3 years ago

Share this post

“We are impressed with the innovation and potential of MIM Fertility and their commitment to addressing real-world issues in reproductive health,” emphasizes Piotr Pietrzak of Tangent Line Ventures. “Their approach to applying artificial intelligence to improve infertility treatment outcomes is exactly what modern medicine needs.”

With great excitement, we want to share the news that we have just completed our Seed funding round, securing an impressive 2 million USD from Tangent Line Ventures and Peleton. This is not just significant financial support but also a sign of trust in our mission and the innovation of the MIM Fertility. 🌟💫

MIM Fertility is our answer to the challenges associated with infertility treatment – we combine advanced AI technologies with reproductive medicine to open new doors for couples around the world. Our cutting-edge AI-powered software platforms, EMBRYOAID and FOLLISCAN, represent the most effective and innovative solutions when it comes to the identification and analysis of ovarian follicles and embryo quality assessment. 🧬🔍

Thanks to this investment, we will be able to further refine our technologies, develop new functionalities, and expand our presence in international markets. This is a significant step towards realizing our mission: empowering fertility professionals with AI tools that support them to fulfill every couple’s dream of parenthood. 👶💞

Our heartfelt thanks to our investors for their support and trust in our TEAM and our mission.

More info about Tangent Line Ventures:
https://tangentline.ventures/

#MIMFertility #AIinMedicine #HealthcareInnovation #SeedFunding #FutureOfInfertilityTreatment

Share this post

You might be also interested in

View all posts

Breaking news from MIM Fertility

1 week ago

Winning Over the Embryologist Who Thinks AI Is a Threat

Article written by Keshav Malhotra – Embryologist · Chair Embryology, ISAR · Chair, Embryology SIG, ASPIRE · Executive Member, Alpha Scientists in Reproductive Medicine A colleague of mine, a senior embryologist with over two decades in the lab, sat across from me at a conference dinner last year and said something I have been […]

3 weeks ago

We Don’t Have to Build Alone: MIM Fertility Partners with Esco Medical

There’s a question every MedTech company must answer at some point: do you build everything yourself, or do you find the right people to build with? For us, the answer just became official. We’re proud to announce that MIM Fertility has entered a formal partnership with Esco Medical – integrating our AI embryo assessment tool, […]

1 month ago

Fertility Nurses in IVF Clinics: The Clinical Backbone of Modern Fertility Care

In every high-performing IVF clinic, there is a role that rarely makes it onto a conference stage or a marketing brochure and yet, without it, the entire treatment chain can slow down, fragment, or fail. The fertility nurse. Patients often interact with nurses more frequently than with their reproductive endocrinologist. Embryologists rely on them to translate […]

2 months ago

FOLLISCAN sets a new standard with FDA 510(k) Clearance

We are proud to announce that our flagship product FOLLISCAN has officially received FDA 510(k) clearance. This milestone positions our company among an elite group of global innovators who meet the world’s most rigorous medical safety standards. This milestone marks a critical turning point in addressing one of the most persistent challenges in the field: […]

3 months ago

AI Embryo Selection in IVF: How Artificial Intelligence Supports Embryologists

A multicentre IVF study recently published in RBMO called “Evaluating the concordance between AI-based and conventional embryo selection: implications for clinical decision-making” shows AI embryo selection achieved 70.1% accuracy, outperforming most embryologists and supporting AI-assisted embryo assessment in IVF. Selecting the embryo with the highest chance of implantation remains one of the most important and […]

View all posts

News